ENTITY

Cellid (299660 KS)

22
Analysis
Health CareSouth Korea
Cellid, Co., Ltd. develops biotechnology. The Company develops innovative immunotherapeutic vaccines, immunology and molecular biology technology, and other related products. Cellid also manufactures and distributes pharmaceuticals and functional foods.
more
Refresh
bullishGOLFZON
27 Mar 2022 15:21

KOSDAQ150 Index Rebalance Preview (June): Potential Inclusions Starting to Outperform

With 80% of the review period complete, there are 15 potential index changes. The potential inclusions have started to outperform the index and the...

Logo
390 Views
Share
bullishNexon GT Co Ltd
27 Mar 2022 06:02

KOSDAQ150 Rebalance in June 2022 Amid Ongoing War in Ukraine

We discuss the potential additions and deletions in the upcoming June 2022 KOSDAQ150 rebalance. The ongoing war in Ukraine has impacted the...

Logo
323 Views
Share
bullishEnchem
17 Feb 2022 07:00

Potential Additions and Deletions to KOSDAQ150 Rebalance in June 2022

We discuss the potential additions and deletions in the upcoming June 2022 KOSDAQ150 rebalance. The top 10 potential inclusions are on average down...

Logo
255 Views
Share
bullishWYSIWYG Studios
06 Jan 2022 05:08

KOSDAQ150 Index Rebalance Preview (June 2022): Lots of Changes Early in the Review Period

A third of the way through the review period, we see 14 potential changes to the KOSDAQ150 Index at the June rebalance. A reversal in performance...

Logo
411 Views
Share
09 Dec 2021 03:19

Short Position Approach on the Index Entrants on December 10 in Korea

The effective date for rebalancing KOSPI 200 and KOSDAQ 150 is this Friday, meaning that this is the first trading day that short selling is...

Logo
257 Views
Share
x